BOARD OF DIRECTORS

Appointed as President Director for the first period based on the Resolutions of the Annual General Meeting of Shareholders (AGMS) for the 2021 Fiscal Year on May 11, 2022.

Completed Bachelor of Science and Master of Science in Industrial Engineering, Texas A&M University, USA. Previously served as President Director at PT Medela Potentia (2020), President & CEO of General Electric Healthcare ASEAN (2010-2016), President of GE Indonesia (2009-2010)

Appointed as Director of Finance & Risk Management for the first period based on the Resolutions of the Annual General Meeting of Shareholders (GMS) for Fiscal Year 2020 on April 28, 2021 to serve until the GMS for Fiscal Year 2025.

She holds a Masters in Management from the University of Indonesia and a Bachelor in Agriculture from Andalas University. Her previous positions were SEVP Corporate Banking at PT Bank Rakyat Indonesia (Persero) Tbk (2019-2021), Head of Agribusiness Division PT BRI (Persero) Tbk (2018-2019), and Head of Credit Risk Analysis Division at PT BRI (Persero) Tbk ( 2016-2017).

Appointed as Commercial Director for the first period based on the Resolutions of the 2022 Extraordinary General Meeting of Shareholders (EGMS) on 14 October 2022 to serve until the 2027 Fiscal Year General Meeting of Shareholders.

Completed her Bachelor of Economics education at STIE IBB. The positions she has held are President Director of PT Kimia Farma Trading & Distribution (2021-2022), Marketing Director of PT Phapros Tbk (2016-2021), Operations Director of PT Rajawali Nusindo (2012-2016).

Appointed as Director General & Human Capital for the first period based on the Resolutions of the General Meeting of Shareholders (GMS) for Fiscal Year 2018 on 7 May 2019 to serve until the GMS for Fiscal Year 2024.

Completed HR Executive Program education at the University of Michigan. Previously, he earned a Master of Management at Gadjah Mada University and Industrial Engineering, STT Telkom Indonesia. The positions that have been held are VP of Human Capital Development, PT Telkom Indonesia (2016-2019), VP Human Capital Strategic Management, PT Telkomsel (2012-2016) and VP Human Capital Management, PT Graha Sarana Duta (2010-2012)

Appointed as Director of Production & Supply Chain for the first period based on the Resolutions of the Extraordinary General Meeting of Shareholders (EGMS) for Fiscal Year 2018 on September 18, 2019 to serve until the AGMS for Fiscal Year 2024 which previously had been appointed as Director of Business Development based on the Decree GMS dated 7 May 2019.

Completed his Masters in Strategic Management at PPM School of Management and completed his professional education in pharmacists at Andalas University. Several positions that have been held are Director of Operations of PT Kimia Farma Trading & Distribution (2017 - 2019), General Manager of SBU Farma PT Kimia Farma Tbk (2012-2017), and Operational Manager of PT Kimia Farma Trading & Distribution (2011-2012)

Appointed for the first time as Director of Portfolio and Business Development based on the Resolutions of the 2019 Extraordinary General Meeting of Shareholders (EGMS) on 18 August 2021 to serve until the 2025 Fiscal Year General Meeting of Shareholders

Completed Master of Science in Cellular and Molecular Biology, San Francisco State University and Doctorate in Biochemistry & Molecular Biology, University of California San Francisco. Some of the positions she has held are Director, European Medical & Technical Affairs, The Procter & Gamble Company, Head, Global Medical & Technical Affairs, The Procter & Gamble Company and Head, Asia-Pacific Regulatory Affairs The Procter & Gamble Company